Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1

Pediatric Blood & Cancer(2025)10.1002/pbc.31606Source: DataRank Database

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1 is a research paper published in Pediatric Blood & Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.36)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Yue Wu ORCID,Kathleen M. McCarten ORCID,Lindsay A. Renfro ORCID,Qinglin Pei ORCID,Kara M. Kelly ORCID

Live enrichment

PubMed:39953678 PMC:PMC11934935 OpenAlex:https://openalex.org/W4407590310

NCI NIH HHS

Grant: U10 CA180886

NCI NIH HHS

Grant: U10 CA180899

NCI NIH HHS

Grant: R50 CA285492

St. Baldrick's Foundation

NIH HHS

National Institutes of Health

St. Baldrick's Foundation

FWCI

2.36

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://doi.wiley.com/10.1002/tdm_license_1.1

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11934935/

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31606

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/pbc.31606

journalhttps://doi.org/10.1002/pbc.31606

Fields of Study

Lymphoma Diagnosis and TreatmentLung Cancer Treatments and MutationsCNS Lymphoma Diagnosis and Treatment

MeSH Terms

AdolescentAdultAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolCyclophosphamideDoxorubicinFemaleFollow-Up StudiesHodgkin DiseaseHumansMalePrednisonePrognosisRetrospective StudiesVincristineSurvival RatePositron-Emission TomographyYoung Adult

Keywords

MedicineVincristineLymphomaInternal medicineCyclophosphamideOncologyPositron emission tomographyChemotherapyPrednisoneHodgkin lymphomaNuclear medicinePediatricNodular Lymphocyte‐predominant Hodgkin Lymphoma

Sustainable Development Goals

SDG 0: Good health and well-being